Viking Therapeutics Inc.’s stock soared 8% Wednesday, after the maker of a promising weight-loss pill secured a manufacturing ...

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

Viking Holdings Ltd. is banking on affluent customers to see it through this period of jitters in the travel industry.

Viking Holdings (NYSE:VIK) reports robust Q4 growth with a 20.5% sales surge and plans to expand in 2025. Discover key ...

An exhibition delving into the legacy of the Vikings on the Isle of Man has opened. The display at Rushen Heritage Centre ...

Greenland is having a moment in the international spotlight as U.S. President Donald Trump maneuvers to gain control of the ...

Viking announced a supply deal with CordenPharma that sets it up for a standalone path to the obesity market. Read why I ...

Goldman Sachs analyst Lizzie Dove reiterated a Neutral rating on the shares of Viking Holdings Ltd (NYSE:VIK) and raised the ...

CordenPharma, a CDMO focused on peptides and peptide-based therapeutics, announced a partnership with Viking Therapeutics. The two companies will work together to ensure the production of Viking’s GLP ...

Viking Holdings told investors Tuesday during its Q4 earnings call that the company has sold 88% of 2025 inventory, with ...

Less than a year after CordenPharma earmarked a major chunk of change to beef up in peptide manufacturing for GLP-1s and ...

Viking set new booking and revenue records, continuing strong performance from 2024, with high demand and successful ...